ORBIMED ADVISORS LLC 13D/13G Filings for Forte Biosciences, Inc. (FBRX)

ORBIMED ADVISORS LLC 13D and 13G filings for Forte Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-02-11
4:22 pm
Sale		2021-12-3113GForte Biosciences, Inc.
FBRX		ORBIMED ADVISORS LLC0
0.000%		-25,431decrease
(Position Closed)		Filing
2021-02-12
4:48 pm
Purchase		2020-12-3113GForte Biosciences, Inc.
FBRX		ORBIMED ADVISORS LLC25,431
4.740%		25,431increase
(New Position)		Filing